CFLAR and cancer: The results indicated that cordycepin prevents constitutive NF-κB signaling, resulting in the stimulation of the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression and the consequent activation of the Bax/caspase-3/PARP-mediated pathway, thus triggering cancer cell death.